Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Longitudinal modeling of cognitive decline in a non-demented elderly population
EF 2011-12
Résumé
Alzheimer disease (AD) and other dementias represent one of the most important public health challenges facing modern society. Presently, 36 million people worldwide live with dementia and this number is projected to reach 66 million by 2030, and 115 million by 2050.
Cognitive decline is the primary symptom of clinical AD. However, the magnitude and rate of cognitive decline varies significantly between individuals. Little is known about what makes an individual follow a particular path of decline, or indeed the specific trajectories of these different paths. Statistical modeling of cognitive data obtained over time from groups of at-risk individuals is needed to identify these different paths. We propose using a new statistical methodology called growth mixture modeling, which can identify subgroups of individuals who follow similar paths, and are exploring several available longitudinal cohorts of at risk individuals that might serve as the discovery and replication datasets for this work. While cognitive decline is the defining feature of AD, researchers are increasingly using disease biomarkers and imaging data to study disease progression. There is similar variability in change over time in these measures, so this methodology will have application to those outcomes as well.
We expect that identifying these paths will be useful in a number of important ways. It will help us to better characterize exactly who follows a particular path, and to identify risk factors associated with following a particular course of decline. Such knowledge could be of particular public health importance, given the failure of treatments at later stages of the disease. Additionally, we may be able to refine predictions of prognosis for individuals at earlier stages of the disease. Finally, it may also provide insights into the underlying causes of disease progression in AD.
Programme
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
257540
Name
Sajeev Gautam
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
Longitudinal modeling of cognitive decline in a non-demented elderly population
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Alzheimer'S Disease; Biomarkers; Biostatistics; Cognitive Decline; Cohort; Dementia; Epidemiology; Growth Mixture Modelling; Longitudinal; Public Health
Abstract
Alzheimer disease (AD) and other dementias represent one of the most important public health challenges facing modern society. Presently, 36 million people worldwide live with dementia and this number is projected to reach 66 million by 2030, and 115 million by 2050.
Cognitive decline is the primary symptom of clinical AD. However, the magnitude and rate of cognitive decline varies significantly between individuals. Little is known about what makes an individual follow a particular path of decline, or indeed the specific trajectories of these different paths. Statistical modeling of cognitive data obtained over time from groups of at-risk individuals is needed to identify these different paths. We propose using a new statistical methodology called growth mixture modeling, which can identify subgroups of individuals who follow similar paths, and are exploring several available longitudinal cohorts of at risk individuals that might serve as the discovery and replication datasets for this work. While cognitive decline is the defining feature of AD, researchers are increasingly using disease biomarkers and imaging data to study disease progression. There is similar variability in change over time in these measures, so this methodology will have application to those outcomes as well.
We expect that identifying these paths will be useful in a number of important ways. It will help us to better characterize exactly who follows a particular path, and to identify risk factors associated with following a particular course of decline. Such knowledge could be of particular public health importance, given the failure of treatments at later stages of the disease. Additionally, we may be able to refine predictions of prognosis for individuals at earlier stages of the disease. Finally, it may also provide insights into the underlying causes of disease progression in AD.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sajeev, Gautam
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~